Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Palisade Bio's price to book ratio was 1.7× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 0.2× to 6.7×, with a median of 0.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | −5.0 |
| 2025 | Dec 31, 2025 | 6.7× | +6.4 |
| 2024 | Dec 31, 2024 | 0.3× | −0.1 |
| 2023 | Dec 29, 2023 | 0.4× | −0.3 |
| 2022 | Dec 30, 2022 | 0.6× | −3.6 |
| 2021 | Dec 31, 2021 | 4.3× | +1.5 |
| 2020 | Jan 31, 2020 | 2.8× | +0.4 |
| 2019 | Dec 31, 2019 | 2.4× | −4.0 |
| 2018 | Dec 31, 2018 | 6.4× | −7.1 |
| 2017 | Dec 29, 2017 | 13.5× | −200.7 |
| 2016 | Oct 31, 2016 | 214.2× | +150.4 |
| 2015 | Dec 31, 2015 | 63.8× | −4.3 |
| 2014 | Dec 31, 2014 | 68.1× | −93.8 |
| 2013 | Dec 31, 2013 | 161.9× | +112.9 |
| 2012 | Dec 31, 2012 | 48.9× | −23.8 |
| 2011 | Dec 30, 2011 | 72.7× | – |
See a number that looks wrong?